News

The new lawsuit repeats those concerns, alleging that Kennedy and other political appointees at the U.S. Department of Health ...
The acknowledgment that the well-connected Epstein did not have a list of clients to whom underage girls were trafficked ...
Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...
A 27-year-old man was killed Monday after opening fire at a U.S. Border Patrol facility in McAllen, Texas, authoriti ...
As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Why is Zepbound more effective? Mir Ali, MD, medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, isn’t shocked by the findings.
"Both Wegovy and Zepbound have demonstrated clinically significant weight reduction." "For example, if a patient has fatty liver, we will choose the GLP-1 that is proven to work best for liver ...
The weight loss drug Zepbound (tirzepatide) led to 50 percent more weight loss in a 72-week trial than Wegovy (semaglutide). Participants taking Zepbound lost 50 pounds (lb) on average, compared ...
Nearly 32% of Zepbound users ultimately lost at least a quarter of their body weight, compared with just 16% of Wegovy users. In both groups, weight loss was about 6% lower in men than in women.
Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s Wegovy in the first head-to-head study of the rival medicines.